Terms: = Liver cancer AND CLIP1, ENSG00000130779, 6249, P30622, RSN, MGC131604, CYLN1, CLIP170, CLIP-170, CLIP AND Treatment
137 results:
1. Advances in post-operative prognostic models for hepatocellular carcinoma.
He Z; She X; Liu Z; Gao X; Lu LU; Huang J; Lu C; Lin Y; Liang R; Ye J
J Zhejiang Univ Sci B; 2023 Mar; 24(3):191-206. PubMed ID: 36915996
[TBL] [Abstract] [Full Text] [Related]
2. Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment.
Chen CT; Feng YH; Yen CJ; Chen SC; Lin YT; Lu LC; Hsu CH; Cheng AL; Shao YY
Hepatol Int; 2022 Oct; 16(5):1199-1207. PubMed ID: 35986846
[TBL] [Abstract] [Full Text] [Related]
3. [Efficacy Evaluation of Three Endoscopic Therapies of Isolated Gastric Varices with Modified Tissue Adhesive].
Ai ZL; Min M; Hu JL; Liang XX; Zhou YL; Ma JL; Jiang Y; He LL; Li P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 May; 53(3):386-390. PubMed ID: 35642143
[TBL] [Abstract] [Full Text] [Related]
4. Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study.
Dutta D; Tatineni T; Yarlagadda S; Gupte A; Reddy SK; Madhavan R; Nair H; Sasidharan A; Kannan R; Pottayil SG; Holla R; Sudhindran S
Indian J Gastroenterol; 2021 Aug; 40(4):389-401. PubMed ID: 34694581
[TBL] [Abstract] [Full Text] [Related]
5. Port site metastases a year after initial laparoscopic cholecystectomy. Should the use of retrieval bags during laparoscopic cholecystectomy be the new gold standard?
Petryshyn N; Dražić T; Hogendorf P; Strzelczyk J; Strzałka A; Szwedziak K; Durczyński A
Pol Przegl Chir; 2021 May; 93(6):61-65. PubMed ID: 36169533
[TBL] [Abstract] [Full Text] [Related]
6. Robotic hepatectomy and biliary reconstruction for perihilar cholangiocarcinoma: a pioneer western case series.
Cillo U; D'Amico FE; Furlanetto A; Perin L; Gringeri E
Updates Surg; 2021 Jun; 73(3):999-1006. PubMed ID: 33861401
[TBL] [Abstract] [Full Text] [Related]
7. Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization.
Hsu SJ; Xu X; Chen MP; Zhao ZY; Wang Y; Yin X; Zhang L; Ge NL; Chen Y; Wang YH; Luo JF; Ren ZG; Chen RX
Acad Radiol; 2021 Nov; 28 Suppl 1():S157-S166. PubMed ID: 33653656
[TBL] [Abstract] [Full Text] [Related]
8. Gastrointestinal tract injuries after thermal ablative therapies for hepatocellular carcinoma: A case report and review of the literature.
Rogger TM; Michielan A; Sferrazza S; Pravadelli C; Moser L; Agugiaro F; Vettori G; Seligmann S; Merola E; Maida M; Ciarleglio FA; Brolese A; de Pretis G
World J Gastroenterol; 2020 Sep; 26(35):5375-5386. PubMed ID: 32994695
[TBL] [Abstract] [Full Text] [Related]
9. Lateral approach toward hepatoduodenal ligament during laparoscopic radical cholecystectomy for Gallbladder cancer.
Paik KY
Surg Oncol; 2020 Sep; 34():146. PubMed ID: 32891320
[TBL] [Abstract] [Full Text] [Related]
10. Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma.
Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Lei HJ; Su CW; Lee RC; Hou MC; Huo TI
Sci Rep; 2020 Mar; 10(1):3925. PubMed ID: 32127619
[TBL] [Abstract] [Full Text] [Related]
11. Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma.
Vogeler M; Mohr I; Pfeiffenberger J; Sprengel SD; Klauss M; Teufel A; Chang DH; Springfeld C; Longerich T; Merle U; Mehrabi A; Weiss KH; Mieth M
J Cancer Res Clin Oncol; 2020 Apr; 146(4):1033-1050. PubMed ID: 32107625
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy of Current Traction Techniques for Endoscopic Submucosal Dissection.
Abe S; Wu SYS; Ego M; Takamaru H; Sekiguchi M; Yamada M; Nonaka S; Sakamoto T; Suzuki H; Yoshinaga S; Matsuda T; Oda I; Saito Y
Gut Liver; 2020 Nov; 14(6):673-684. PubMed ID: 31887810
[TBL] [Abstract] [Full Text] [Related]
13. Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes.
Katsuda T; Matsuzaki J; Yamaguchi T; Yamada Y; Prieto-Vila M; Hosaka K; Takeuchi A; Saito Y; Ochiya T
Elife; 2019 Aug; 8():. PubMed ID: 31393263
[TBL] [Abstract] [Full Text] [Related]
14. Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma.
Jouve JL; Lecomte T; Bouché O; Barbier E; Khemissa Akouz F; Riachi G; Nguyen Khac E; Ollivier-Hourmand I; Debette-Gratien M; Faroux R; Villing AL; Vergniol J; Ramee JF; Bronowicki JP; Seitz JF; Legoux JL; Denis J; Manfredi S; Phelip JM;
J Hepatol; 2019 Sep; 71(3):516-522. PubMed ID: 31125576
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic factors of survival during hepatocellular carcinoma.
Bibani N; Trad D; Sabbah M; Ouakaa A; Elloumi H; Gargouri D; Kharrat J
Tunis Med; 2018 Jun; 96(6):379-384. PubMed ID: 30430477
[TBL] [Abstract] [Full Text] [Related]
16. The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular Carcinoma.
Op den Winkel M; Nagel D; Op den Winkel P; Paprottka PM; Schmidt L; Bourhis H; Trojan J; Goeller M; Reiter FP; Stecher SS; De Toni EN; Gerbes AL; Kolligs FT
Digestion; 2019; 100(1):15-26. PubMed ID: 30282074
[TBL] [Abstract] [Full Text] [Related]
17. Usefulness of the modified clip-with-line method for endoscopic mucosal treatment procedure.
Soga K; Shimomura T; Suzuki T; Tei T; Usui T; Inagaki Y; Kassai K; Itani K
J Gastrointestin Liver Dis; 2018 Sep; 27(3):317-320. PubMed ID: 30240476
[TBL] [Abstract] [Full Text] [Related]
18. Nitroglycerine use in transcatheter arterial (chemo) embolization in patients with hepatocellular carcinoma: Five-year retrospective study.
Liu YS; Lin CY; Chuang MT; Tsai YS; Wang CK; Ou MC
Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):542-552. PubMed ID: 29859998
[TBL] [Abstract] [Full Text] [Related]
19. Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial.
Walter I; Schulz U; Vogelhuber M; Wiedmann K; Endlicher E; Klebl F; Andreesen R; Herr W; Ghibelli L; Hackl C; Wiest R; Reichle A
Med Oncol; 2017 Nov; 34(12):192. PubMed ID: 29098441
[TBL] [Abstract] [Full Text] [Related]
20. SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center.
Qiu H; Moravan MJ; Milano MT; Usuki KY; Katz AW
J Gastrointest Cancer; 2018 Dec; 49(4):463-469. PubMed ID: 28710606
[TBL] [Abstract] [Full Text] [Related]
[Next]
